Cited by 106

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Regulation of the angiopoietin-like protein 3 gene by LXR

Kaplan, Rebecca, Zhang, Theresa, Hernandez, Melba, Gan, Frank Xiaodong, Wright, Samuel D., Waters, M.Gerard, Cai, Tian-Quan·2003·Journal of Lipid Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m200367-jlr200

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Cholesterol feeding raises the level of Angptl3 mRNA in mouse liver. Mice were fed with a normal chow diet or with the same supplemented with 4% of cholesterol for 7 days. On the 8th day, mice were euthanized, RNAs were prepared from the liver samples, and the relative levels of Angptl3 and CYP7A mRNAs were measured as described in Materials and Methods. Results are normalized to the values obtained from normal chow diet fed mice, and data are shown as the means ± SE of each group (n = 5).
Fig. 1 Cholesterol feeding raises the level of Angptl3 mRNA in mouse liver. Mice were fed with a normal chow diet or with the same supplemented with 4% of cholesterol for 7 days. On the 8th day, mice were euthanized, RNAs were prepared from the liver samples, and the relative levels of Angptl3 and CYP7A mRNAs were measured as described in Materials and Methods. Results are normalized to the values obtained from normal chow diet fed mice, and data are shown as the means ± SE of each group (n = 5).CC-BY · From the PDF
Fig. 2 LXR-selective agonist T0901317 increases levels of plasma lipids and Angptl3 mRNA in the liver. Mice were orally treated with either vehicle or 10 mpk (mg compound/kg of animal body weight/day) of T0901317 for 7 days. On the 8th day, mice were euthanized, and (A) plasma levels of total cholesterol (TC), HDL cholesterol (HDL-C), and triglycerides (TG), or (B) levels of Angptl3 mRNA in the liver were measured. Lipid data are reported as the percent of changes from control mice (A, n = 10); Relative Angptl3 mRNA levels in treated mice are calculated by normalizing to the values obtained from control mice (B, n = 5), and data are shown as the mean ± SE of each group.
Fig. 2 LXR-selective agonist T0901317 increases levels of plasma lipids and Angptl3 mRNA in the liver. Mice were orally treated with either vehicle or 10 mpk (mg compound/kg of animal body weight/day) of T0901317 for 7 days. On the 8th day, mice were euthanized, and (A) plasma levels of total cholesterol (TC), HDL cholesterol (HDL-C), and triglycerides (TG), or (B) levels of Angptl3 mRNA in the liver were measured. Lipid data are reported as the percent of changes from control mice (A, n = 10); Relative Angptl3 mRNA levels in treated mice are calculated by normalizing to the values obtained from control mice (B, n = 5), and data are shown as the mean ± SE of each group.CC-BY · From the PDF
Fig. 3 Concentration-dependent induction of Angptl3 expression by LXR agonists. HepG2 cells (5 × 10 5 cells/well) were plated in 6-well plates and treated with (A) buffer, increasing concentrations of 22( R )-OH Ch or 30 𝛍 M 22( S )-OH Ch or (B) buffer, or increasing concentrations of T0901317. Following H11601 16 h of incubation at 37 ° C, RNA samples were prepared from the cultured cells, and expression levels of Angptl3 mRNA were measured as described in Materials and Methods. Results are normalized to the values obtained from control cells, and data are shown as the means of duplicate determinations.
Fig. 3 Concentration-dependent induction of Angptl3 expression by LXR agonists. HepG2 cells (5 × 10 5 cells/well) were plated in 6-well plates and treated with (A) buffer, increasing concentrations of 22( R )-OH Ch or 30 𝛍 M 22( S )-OH Ch or (B) buffer, or increasing concentrations of T0901317. Following H11601 16 h of incubation at 37 ° C, RNA samples were prepared from the cultured cells, and expression levels of Angptl3 mRNA were measured as described in Materials and Methods. Results are normalized to the values obtained from control cells, and data are shown as the means of duplicate determinations.CC-BY · From the PDF
Fig. 4 Comparison of the genomic regions upstream of Angptl3 in human and mouse. Genomic regions spanning Angptl3 in human and mouse were compared using mVISTA (http://www.gsd.lbl.gov/vista). Conserved regions with an identity greater than or equal to 50% between human and mouse sequences are shown as peaks of similarity (vertical axes) relative to the positions along the mouse genomic sequence (horizontal axes). Peaks representing highly conserved regions (identity > 75% over > 100 bp) are shaded if they overlap with non-coding regions, or marked by slanted lines if they overlap with exons. There are two highly conserved non-coding regions upstream of human and mouse Angptl3: the 500 bp region immediately upstream and the 150 bp region 2.5 kb upstream of the gene.
Fig. 4 Comparison of the genomic regions upstream of Angptl3 in human and mouse. Genomic regions spanning Angptl3 in human and mouse were compared using mVISTA (http://www.gsd.lbl.gov/vista). Conserved regions with an identity greater than or equal to 50% between human and mouse sequences are shown as peaks of similarity (vertical axes) relative to the positions along the mouse genomic sequence (horizontal axes). Peaks representing highly conserved regions (identity > 75% over > 100 bp) are shaded if they overlap with non-coding regions, or marked by slanted lines if they overlap with exons. There are two highly conserved non-coding regions upstream of human and mouse Angptl3: the 500 bp region immediately upstream and the 150 bp region 2.5 kb upstream of the gene.CC-BY · From the PDF
Fig. 5 Analysis of the promoter region of human and mouse Angptl3. The sequence segment overlapping the 5 ′ RACE product is shown in italic, and its 5 ′ end is marked by arrow as the putative transcription start sites (i.e., position + 1 in the sequences). The translational start codon (i.e., ATG) is also marked by an arrow. A number of putative binding sites of transcription factors are predicted in this region. Those conserved between human and mouse are boxed, and those found in only one species are underlined.
Fig. 5 Analysis of the promoter region of human and mouse Angptl3. The sequence segment overlapping the 5 ′ RACE product is shown in italic, and its 5 ′ end is marked by arrow as the putative transcription start sites (i.e., position + 1 in the sequences). The translational start codon (i.e., ATG) is also marked by an arrow. A number of putative binding sites of transcription factors are predicted in this region. Those conserved between human and mouse are boxed, and those found in only one species are underlined.CC-BY · From the PDF
Fig. 6 Effect of LXR agonists on activity of a truncated Angptl3 promoter in HepG2 cells. A fragment of the human Angptl3 promoter (from -953 to + 49 bp) with or without mutations at the DR4 element was linked to the firefly luciferase reporter gene. The resulting plasmid was cotransfected with a control reporter plasmid expressing Renilla luciferase into HepG2 cells. Cells were treated with (A) buffer, 10 𝛍 M of 22( R )-OH Ch, 25-OH Ch, 22( S )-OH Ch, 9-cis-retinoic acid (9-RA), or both 9-RA and 22( R )-OH Ch; or (B) buffer or increasing concentrations of T0901317 or combination of T0901317 (1 𝛍 M) and 9-RA (10 𝛍 M). After 42 h, the cells were lysed and relative luciferase activities were measured. Results are expressed as a ratio between the firefly and Renilla luciferase activities, and data are shown as the means ± SD of triplicates of a representative experiment. Three to four independent experiments were performed with similar results.
Fig. 6 Effect of LXR agonists on activity of a truncated Angptl3 promoter in HepG2 cells. A fragment of the human Angptl3 promoter (from -953 to + 49 bp) with or without mutations at the DR4 element was linked to the firefly luciferase reporter gene. The resulting plasmid was cotransfected with a control reporter plasmid expressing Renilla luciferase into HepG2 cells. Cells were treated with (A) buffer, 10 𝛍 M of 22( R )-OH Ch, 25-OH Ch, 22( S )-OH Ch, 9-cis-retinoic acid (9-RA), or both 9-RA and 22( R )-OH Ch; or (B) buffer or increasing concentrations of T0901317 or combination of T0901317 (1 𝛍 M) and 9-RA (10 𝛍 M). After 42 h, the cells were lysed and relative luciferase activities were measured. Results are expressed as a ratio between the firefly and Renilla luciferase activities, and data are shown as the means ± SD of triplicates of a representative experiment. Three to four independent experiments were performed with similar results.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Loughna, 2001, Angiopoietin and Tie signaling pathways in vascular development, Matrix Biol., 20, 319, 10.1016/S0945-053X(01)00149-4 · DOI
  2. Koishi, 2002, Angptl3 regulates lipid metabolism in mice, Nat. Genet., 30, 151, 10.1038/ng814 · DOI · Paper page
  3. Kondo, 1957, Inbred strains resulted from Japanese mice, Bull. Exp. Anim., 6, 107, 10.1538/expanim1957.6.4_107 · DOI
  4. Nakamura, 1962, A diabetic strain of the mouse, Proc. Jpn. Acad., 38, 348, 10.2183/pjab1945.38.348 · DOI
  5. Nakamura, 1967, Studies on a diabetic (KK) strain of mice, Diabetologia., 3, 212, 10.1007/BF01222198 · DOI
  6. Repa, 2000, The role of orphan nuclear receptors in the regulation of cholesterol homeostasis, Annu. Rev. Cell Dev. Biol., 16, 459, 10.1146/annurev.cellbio.16.1.459 · DOI
  7. Repa, 2000, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev., 14, 2819, 10.1101/gad.844900 · DOI
  8. Joseph, 2002, Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors, J. Biol. Chem., 277, 11019, 10.1074/jbc.M111041200 · DOI
  9. Zhang, 2001, Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta, J. Biol. Chem., 276, 43018, 10.1074/jbc.M107823200 · DOI
  10. Schultz, 2000, Role of LXRs in control of lipogenesis, Genes Dev., 14, 2831, 10.1101/gad.850400 · DOI · Paper page
  11. Shimano, 1997, Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells, J. Clin. Invest., 99, 846, 10.1172/JCI119248 · DOI · Paper page
  12. Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res., 25, 3389, 10.1093/nar/25.17.3389 · DOI · Paper page
  13. Dubchak, 2000, Active conservation of noncoding sequences revealed by three-way species comparisons, Genome Res., 10, 1304, 10.1101/gr.142200 · DOI
  14. Mayor, 2000, VISTA: visualizing global DNA sequence alignments of arbitrary length, Bioinformatics., 16, 1046, 10.1093/bioinformatics/16.11.1046 · DOI
  15. Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Res., 22, 4673, 10.1093/nar/22.22.4673 · DOI · Paper page
  16. Wingender, 2000, TRANSFAC: an integrated system for gene expression regulation, Nucleic Acids Res., 28, 316, 10.1093/nar/28.1.316 · DOI
  17. Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha, Cell., 93, 693, 10.1016/S0092-8674(00)81432-4 · DOI
  18. Venkateswaran, 2000, Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols, J. Biol. Chem., 275, 14700, 10.1074/jbc.275.19.14700 · DOI
  19. Schwartz, 2000, ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR, Biochem. Biophys. Res. Commun., 274, 794, 10.1006/bbrc.2000.3243 · DOI
  20. Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J. Biol. Chem., 275, 28240, 10.1074/jbc.M003337200 · DOI
  21. Landschulz, 1989, The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite, Science., 243, 1681, 10.1126/science.2494700 · DOI
  22. Ryffel, 2001, Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences, J. Mol. Endocrinol., 27, 11, 10.1677/jme.0.0270011 · DOI
  23. Sladek, 1990, Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily, Genes Dev., 4, 2353, 10.1101/gad.4.12b.2353 · DOI · Paper page
  24. Davis, 1996, Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning, Cell., 87, 1161, 10.1016/S0092-8674(00)81812-7 · DOI · Paper page
  25. Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science., 277, 55, 10.1126/science.277.5322.55 · DOI · Paper page
  26. Shimizugawa, 2002, ANGPTL3 decreases VLDL triglyceride clearance by inhibition of lipoprotein lipase, J. Biol. Chem., 277, 33742, 10.1074/jbc.M203215200 · DOI · Paper page
  27. Grefhorst, 2002, Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles, J. Biol. Chem., 277, 34182, 10.1074/jbc.M204887200 · DOI

Cited by

Sorted by citations

See all 106

Metadata

Authors
Kaplan, R., Zhang, T., Hernandez, M., Gan, F. X., Wright, S. D., Waters, M. G., & Cai, T.-Q.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2003-01
Volume
44
Issue
1
Pages
136-143
ISSN
0022-2275
Cited by
106
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review